Skip to main content
. 2020 Jun 25;5(5):984–993. doi: 10.1016/j.adro.2020.06.006

Table 3.

Cumulative lung doses with and without conversion to EQD2 Gy3 (n = 44 at the patient level; n = 108 at the tumor level)

Variable N Mean SD Median Interquartile range
Range
Q1 Q3 Min Max
V5 EQD2 44 40.93 17.26 37.45 28.10 50.75 14.20 78.00
V10 EQD2 44 25.49 13.26 21.70 16.70 31.20 7.40 61.70
V20 EQD2 44 14.73 9.06 13.15 8.25 17.50 3.80 46.10
V30 EQD2 44 10.23 6.48 9.70 5.75 11.95 2.60 34.40
V40 EQD2 44 7.69 4.48 7.60 4.65 9.00 2.00 26.50
V5 44 47.43 18.24 44.43 33.06 57.25 18.34 84.24
V10 44 27.26 14.98 24.39 17.74 30.62 7.01 70.66
V20 44 12.32 10.25 9.96 6.29 12.49 2.53 52.39
V30 44 7.29 7.84 5.37 3.68 7.26 1.36 44.77
V40 44 4.67 5.83 3.11 2.14 4.45 0.78 32.71
Mean lung dose EQD2 44 12.42 5.12 11.45 8.49 15.44 4.55 26.52
Mean lung dose 44 9.38 4.85 8.55 6.38 10.36 4.05 28.38

Abbreviation: EQD2 = equivalent dose in 2 Gy fractions; Max = maximum; Min = minimum; SD = standard deviation.